Phase II trial investigating the efficacy and tolerability of rezatomidine in patients with functional heartburn undergoing mechanical esophageal stimulation and chemical esophageal stimulation

Trial Profile

Phase II trial investigating the efficacy and tolerability of rezatomidine in patients with functional heartburn undergoing mechanical esophageal stimulation and chemical esophageal stimulation

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2010

At a glance

  • Drugs Rezatomidine (Primary)
  • Indications Heartburn
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jun 2010 New trial record
    • 04 May 2010 Results have been presented at Digestive Disease Week (DDW) 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top